Drugs / MD05
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00519155 | Jul 2007 → Oct 2008 | periodontal disorder | Scil Technology GmbH | Unknown | No outcome recorded |
| Phase 2 | NCT00520377 | Jan 2005 → Dec 2007 | — | Scil Technology GmbH | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MD05 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00520377 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human GDF-5” NCT00519155 ↗ |